GSK, which already makes drugs in Kenya, Nigeria and South Africa, is now looking at sites for additional facilities in countries including Ghana, Ethiopia and Rwanda, a company spokeswoman said.

South Africa generic drugmaker Aspen Pharmacare Holdings Ltd (APNJ.J) has teamed up with shareholder GlaxoSmithKline Plc (GSK) (GSK.L) to extend its presence in Japan, a lucrative market for low ...

GSK is teaming up with the U.K. and South African Medical Research Councils in a $8.07 million collaboration aimed at supporting research into noncommunicable diseases in Africa.

GSK already has manufacturing plants in Nigeria, Kenya and South Africa. It also is looking at its supply chain to find ways to get more medicines to rural areas that can be difficult to reach.

Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon.

We have launched a new five-year partnership with GlaxoSmithKline (GSK) to enhance the capabilities of African scientists in modern analytical skills.

GSK (GSK) has reportedly delivered the first shipment of its malaria vaccine Mosquirix to Africa, with Cameroon being the first recipient. Read more here.

Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...

South Africa expressed confidence that it can get finance ministers and central bank governors from the Group of 20 nations ...

The partners plan to launch a mid-stage Phase IIb clinical study in Kenya, South Africa and India next year, following successful initial tests with the GSK product, Aeras said on Wednesday.

A team of infectious disease scientists have been awarded £17.9m to identify new drugs to treat fungal infections.

GSK said in June that widespread foreign exchange shortages in Nigeria were negatively impacting its operations. Soon after, the British multinational pharmaceutical and biotechnology company decided ...